Sino Biopharmaceutical Li... (SBMFF)

PNK: SBMFF · Real-Time Price · USD

0.49

0.04 (9.13%)

At close: Apr 22, 2025, 10:13 AM

Sino Biopharmaceutical Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Cash & Equivalents	9.57B	8.55B	8.55B	9.45B	9.45B	11.58B	11.58B	12.07B	12.07B	7.77B	7.77B	10.57B	10.57B	8.03B	7.93B	11.26B	16.1B	17.09B	16.12B	11.91B	6.14B	7.18B	6.19B	6.68B	6.3B	5.54B	5.04B	4.19B	4.93B	3.86B	4.04B	3.77B	3.57B	3.25B	2.34B
Short-Term Investments	5.25B	4.63B	4.63B	1.55B	1.55B	4.1B	160.13M	4.86B	4.86B	7.91B	7.91B	5.23B	569.5M	2.42B	2.4B	5.17B	2.43B	1.98B	1.76B	7.19B	3.31B	2.9B	2.81B	2B	4.29B	3.45B	3.86B	5.72B	3.39B	3.53B	3.33B	4.81B	3.01B	1.86B	1.93B
Long-Term Investments	21.09B	27.41B	27.41B	25.18B	25.18B	20.16B	24.26B	16.96B	25.23B	17.83B	27.43B	20.51B	25.17B	14.76B	12.37B	5.73B	1.99B	465.19M	536.37M	-5.17B	1.21B	-1.69B	1.1B	1.07B	-2.97B	-2.27B	1.1B	-3.94B	-1.79B	-1.82B	-1.82B	-3.4B	-1.27B	-181.04M	-307.87M
Other Long-Term Assets	5.77B	1.27B	1.27B	1.8B	3.78B	5.97B	1.87B	9.5B	2.71B	11.28B	1.67B	5.96B	2.42B	6.39B	4.49B	8.81B	3.45B	3.08B	2.82B	9.87B	1.93B	4.7B	1.7B	1.67B	4.8B	3.87B	1.4B	6.13B	4.01B	4.29B	3.77B	5.27B	4.03B	2.86B	2.93B
Receivables	6.8B	10.21B	7.3B	4.6B	4.6B	7.11B	7.11B	4.64B	4.64B	4.95B	4.95B	4.29B	4.29B	5.06B	3.25B	2.91B	3.71B	4.33B	2.61B	2.71B	3.79B	3.52B	3.09B	2.92B	3.58B	3.24B	2.88B	2.05B	2.34B	2.4B	2.52B	2B	2.3B	2.00	2.02B
Inventory	2.37B	1.84B	1.84B	1.99B	1.99B	2.02B	2.02B	2.33B	2.33B	2.14B	2.14B	1.94B	1.94B	1.73B	1.81B	1.88B	1.76B	1.8B	1.81B	1.66B	1.59B	1.52B	1.34B	1.21B	1.17B	1.2B	1.03B	918.82M	815.89M	873.9M	834.61M	894.64M	820.75M	809.38M	801.02M
Other Current Assets	n/a	60.97M	60.97M	2.52B	2.52B	79.89M	79.89M	1.58B	1.58B	406.92M	406.92M	1.25B	1.25B	115.41M	116.79M	1.16B	148.19M	144.75M	144.92M	630.76M	n/a	n/a	n/a	978.24M	n/a	n/a	n/a	710.33M	n/a	n/a	n/a	1.11B	2.00	2.19B	11.24M
Total Current Assets	24.69B	25.22B	25.22B	23.81B	23.81B	26.98B	26.98B	25.93B	25.93B	25.2B	25.2B	23.5B	23.5B	23.81B	21.79B	22.79B	30.4B	34.4B	32.95B	24.91B	21.86B	21.87B	20.18B	18.54B	18.57B	16.88B	16.72B	13.78B	13.97B	13.23B	14.24B	12.73B	11.81B	9.94B	9.55B
Property-Plant & Equipment	10.29B	9.68B	9.68B	9.91B	9.91B	9.58B	9.58B	9.25B	9.25B	8.77B	8.77B	8.52B	8.52B	8.73B	8.76B	8.39B	8.66B	8.57B	8.34B	6.44B	6.53B	6.17B	5.95B	5.8B	6.27B	5.89B	4.71B	4.27B	3.87B	3.39B	3.16B	3.15B	2.66B	2.58B	2.5B
Goodwill & Intangibles	3.06B	3.12B	3.12B	2.91B	928.94M	2.94B	2.94B	1.91B	940.96M	1.86B	1.86B	1.71B	939.49M	1.82B	1.74B	1.01B	21.2B	21.33B	21.4B	909.99M	21.78B	21.94B	22.05B	22.25B	10.16B	10.15B	10.14B	308.18M	274.8M	276.63M	277.28M	270.35M	282.5M	276.05M	266.02M
Total Long-Term Assets	40.72B	41.48B	41.48B	39.8B	39.8B	38.66B	38.66B	38.13B	38.13B	39.74B	39.74B	37.04B	37.04B	32.39B	27.36B	24.42B	35.8B	33.95B	33.69B	12.6B	31.92B	31.61B	31.26B	31.24B	18.72B	18.11B	17.78B	7.16B	6.62B	6.37B	5.66B	5.65B	5.9B	5.76B	5.57B
Total Assets	65.41B	66.7B	66.7B	63.6B	63.6B	65.64B	65.64B	64.06B	64.06B	64.93B	64.93B	60.54B	60.54B	56.21B	49.15B	47.21B	66.2B	68.35B	66.64B	37.51B	53.77B	53.47B	51.44B	49.78B	37.29B	34.99B	34.5B	20.94B	20.58B	19.61B	19.9B	18.38B	17.71B	15.69B	15.12B
Account Payables	1.5B	2.18B	2.19B	1.33B	1.33B	2.17B	2.17B	1.64B	1.88B	2.68B	3.08B	1.69B	1.79B	1.62B	2.16B	1.95B	2.36B	2.8B	2.72B	1.81B	2.37B	2.4B	2.26B	1.83B	1.66B	841.48M	994.44M	928.61M	807.21M	1.17B	1.33B	826.73M	1.07B	690.46M	676.6M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	115.12M	n/a
Short-Term Debt	7.6B	8.5B	8.5B	11.14B	11.27B	10.48B	10.48B	9.66B	9.8B	4.07B	4.07B	6.52B	6.66B	1.82B	1.21B	1.55B	305.87M	307.57M	86.68M	666.75M	795.75M	787.2M	2.81B	2.91B	3.01B	1.08B	953.26M	741.31M	739.6M	998.82M	1.2B	1.37B	1.24B	1.2B	1.17B
Other Current Liabilities	7.68B	12.48M	11.25B	3.35B	3.21B	14.18B	14.18B	2.24B	2.11B	9.07B	9.07B	1.82B	1.68B	8.02B	6.97B	3.22B	7.24B	7.39B	6.97B	2.06B	6.92B	6.94B	5.84B	4.93B	5.83B	5.77B	5.05B	1.25B	4.64B	4.74B	4.32B	1.07B	4.33B	-115.12M	n/a
Total Current Liabilities	19.56B	21.95B	21.95B	22.61B	22.61B	26.87B	26.87B	20.15B	20.15B	16.27B	16.27B	15.35B	15.35B	11.49B	10.36B	10.94B	9.94B	10.53B	9.8B	8.12B	10.09B	10.14B	10.91B	9.7B	10.5B	7.69B	7B	5.69B	6.19B	6.9B	6.86B	5.66B	6.65B	6.09B	5.5B
Long-Term Debt	2B	1.01B	1.01B	1.07B	1.07B	702.08M	702.08M	3.93B	3.93B	7.54B	7.54B	5.21B	5.21B	11.52B	12.32B	12.36B	13.9B	14.38B	13.84B	7.88B	2.48B	2.39B	541.63M	507.07M	544.06M	2.21B	2.12B	2.21B	2.26B	1.63B	1.66B	1.68B	967.94M	275.64M	272.29M
Other Long-Term Liabilities	201.9M	1.47B	1.47B	1.46B	1.46B	1.29B	1.29B	1.71B	1.71B	2.03B	2.03B	1.94B	1.94B	1.8B	1.36B	1.05B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	204.92K	2.00	1.00	1.00
Total Long-Term Liabilities	3.08B	2.63B	2.63B	2.83B	2.83B	2.32B	2.32B	5.97B	5.97B	9.92B	9.92B	7.47B	7.47B	13.61B	13.94B	13.85B	15.8B	16.31B	15.76B	8.83B	4.55B	4.52B	2.56B	1.55B	1.38B	3B	2.91B	2.64B	2.5B	1.79B	1.86B	2.05B	1.2B	470.93M	483.99M
Total Liabilities	22.63B	24.58B	24.58B	25.43B	25.43B	29.18B	29.18B	26.12B	26.12B	26.19B	26.19B	22.81B	22.81B	25.1B	24.3B	24.79B	25.74B	26.85B	25.56B	16.95B	14.64B	14.66B	13.48B	12.23B	11.89B	10.69B	9.91B	8.32B	8.69B	8.69B	8.72B	7.71B	7.85B	6.56B	5.98B
Total Debt	9.71B	9.68B	9.51B	12.58B	12.64B	11.55B	11.52B	13.98B	14.06B	12.02B	11.97B	12.12B	12.19B	13.65B	13.81B	14.21B	14.28B	14.77B	13.99B	8.62B	3.36B	3.27B	3.35B	3.49B	3.56B	3.29B	3.07B	2.95B	3B	2.63B	2.86B	3.05B	2.21B	1.48B	1.45B
Common Stock	414.38M	414.38M	414.38M	414.62M	414.62M	414.62M	414.62M	414.9M	414.9M	414.94M	414.94M	415.44M	415.44M	415.89M	415.89M	415.89M	416.14M	278.3M	278.31M	278.45M	278.45M	278.45M	278.45M	278.85M	279.21M	279.21M	190.29M	170.03M	170.03M	170.03M	170.03M	165.92M	159.36M	158.5M	154.19M
Retained Earnings	25.28B	31.85B	31.85B	23.65B	29.34B	28.64B	28.64B	28.36B	28.36B	28.54B	28.54B	27.21B	27.21B	21.3B	n/a	13.6B	n/a	19.04B	n/a	11.95B	n/a	n/a	n/a	n/a	n/a	9.36B	n/a	8.47B	n/a	6.07B	n/a	5.34B	n/a	4.88B	n/a
Comprehensive Income	n/a	-9.73B	-9.73B	-5.71B	-9.95B	-15.19B	-9.88B	-15.39B	-10.08B	n/a	-9.85B	-9.23B	-9.23B	-9.36B	n/a	-9.49B	n/a	-299.73M	n/a	-9.83B	n/a	-492.05M	29.81B	-462.85M	n/a	-513.77M	n/a	-587.27M	n/a	n/a	n/a	-848.18M	7.37B	-91.17M	6.69B
Shareholders Equity	31.96B	32.84B	32.84B	30.47B	30.47B	29.99B	29.99B	29.75B	29.75B	30.21B	30.21B	30.29B	30.29B	24.58B	18.67B	16.75B	31.67B	31.51B	31.71B	31.11B	30.58B	29.92B	29.67B	29.21B	20.72B	20.29B	20.07B	9.21B	9.15B	8.64B	8.43B	7.96B	7.53B	7.16B	6.86B
Total Investments	26.34B	32.04B	32.04B	25.82B	26.73B	24.26B	24.42B	25.23B	30.09B	27.43B	35.34B	25.17B	25.74B	17.17B	14.78B	10.91B	4.42B	2.45B	2.3B	2.02B	1.21B	1.21B	1.1B	1.07B	1.32B	1.18B	1.1B	1.78B	1.6B	1.71B	1.51B	1.41B	1.73B	1.68B	1.62B